Off the Hook?
Repurposing nabiximols to tackle cannabis dependency
Jonathan James | | Quick Read
“The concept of prescribing patients a safer form of the drug they are dependent on is not novel; it is routinely used to treat tobacco and heroin addiction,” explains Nicholas Lintzeris, a researcher at New South Wales University, Australia, and part of a team that hopes to apply the same logic to cannabis dependency (1). “The process can encourage behavioral ‘lifestyle’ change, which is necessary to stopping addiction.”
A previous study (2), conducted over a period of 28 days, had already demonstrated promising results with nabiximols (Sativex) – an oromucosal spray, containing THC, CBD and specific minor cannabinoids, which has been approved in “over 25 countries outside the USA for the treatment of spasticity (muscle stiffness/spasm) due to muscular sclerosis (3)”
Read the full article now
Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Cannabis Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.